loader2
Partner With Us NRI

Company details

48.50
51.00
10.64
71.45
6M Return 61.94%
1Y Return 333.04%
Mkt Cap.(Cr) 48.49
Volume 1,930
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 1,930

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: -44.89 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 22,733.13 -38,577.79
LAST 3M 77,375.96 -53,201.90
LAST 6M 142,231.38 -196,897.34
LAST 12M 206,053.08 -176,593.86

Information

  • About Company
  • Company Info
  • Listing Info
10.52
27.35%
-7.583
4.51%
-10.37%
Description
  • Incorporated as a public limited company in Oct.`94, Sanjivani Parenteral is jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry. The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative. The installed capacities for its products will be, 150 lac pa each for liquid vials and powder vials and 73 lac pa for its ampoules, taking the total capacity to 375 lac pa. The company came out with a public issue in Jan.`96 to part-finance the project. The promoters have received firm enquiries from reputed phamaceutical companies like Merind, Lupin Laboratories and USV for the first year` production of liquid vials and ampoules. During the year 1998-99, the Company has been approved by the WHO GMP Certificate. The Company is hoping for export of its products in Africa, Europe & Latin America. The Company has also tied up with Cadila Ltd., Alkem Ltd., Indian Immunologicals Ltd for marketing its products. During the year 1999-2000, the company has tied-up with India`s first ranked pharmaceutical giant Ranbaxy for manufacturing its products.

Read More

No Data Found

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 531569
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : X
ISIN : INE860D01013

ICICIdirect Sanjivani Paranteral Ltd FAQ

You can buy Sanjivani Paranteral Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Sanjivani Paranteral Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 23, 2022 10:29 AM the closing price of Sanjivani Paranteral Ltd was ₹ 48.50.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 23, 2022 10:29 AM, the market cap of Sanjivani Paranteral Ltd stood at ₹ 48.49.
The latest PE ratio of Sanjivani Paranteral Ltd as of May 23, 2022 10:29 AM is 10.52
The latest PB ratio of Sanjivani Paranteral Ltd as of May 23, 2022 10:29 AM is -0.15
The 52-week high of Sanjivani Paranteral Ltd is ₹ 71.45 while the 52-week low is ₹ 10.64 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE